Invasive Pneumococcal Disease in Alaskan Children Impact of the Seven-Valent Pneumococcal Conjugate Vaccine and the Role of Water Supply

被引:93
|
作者
Wenger, Jay D. [1 ]
Zulz, Tammy [1 ]
Bruden, Dana [1 ]
Singleton, Rosalyn [1 ]
Bruce, Michael G. [1 ]
Bulkow, Lisa [1 ]
Parks, Debbie [1 ]
Rudolph, Karen [1 ]
Hurlburt, Debby [1 ]
Ritter, Troy [2 ]
Klejka, Joseph [3 ]
Hennessy, Thomas [1 ]
机构
[1] Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, Anchorage, AK 99508 USA
[2] Alaska Native Tribal Hlth Consortium, Div Environm Hlth & Engn, Anchorage, AK USA
[3] Yukon Kuskokwim Hlth Corp, Bethel, AK USA
关键词
invasive pneumococcal disease; water; pneumococcal conjugate vaccine; Streptococcus pneumoniae; RISK-FACTORS; NONVACCINE SEROTYPES; RESPIRATORY-TRACT; CONJUGATE VACCINE; NATIVE CHILDREN; INFECTIONS; POPULATION; EPIDEMIOLOGY; EMERGENCE; WATER;
D O I
10.1097/INF.0b013e3181bdbed5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Alaska Native (AN) children, especially those in the Yukon-Kuskokwim region (YK-AN children), suffer some of the highest rates of invasive pneumococcal disease (IPD) in the world. Rates of IPD declined after statewide introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in 2001, but increased in subsequent years. Methods: Population-based laboratory surveillance data (1986-2007) for invasive Streptococcus pneumoniae infection in Alaskan children <5 years old were used to evaluate the association of IPD rates and serotype distribution with immunization, socioeconomic status, and in-home water service. Results: Introduction of PCV7 vaccine resulted in elimination of IPD caused by vaccine serotypes, but was followed by increasing rates of IPD caused by nonvaccine serotypes. Among YK-AN children IPD rates dropped by 60%, but then rose due to non-PCV7 serotypes to levels 5- to 10-fold higher than rates in non-YK-AN children and non-AN children. IPD rates in YK-AN children were twice as high in villages where <10% of houses had in-home piped water compared with villages where more than 80% of houses had in-home piped water (390 cases/100,000 vs. 146 cases/100,000, P = 0.008). Conclusions: High IPD rates in Alaska are associated with lack of in-home piped water (controlling for household crowding and per capita income). The effect of in-home piped water is most likely mediated through reduced water supply leading to limitations on handwashing.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 50 条
  • [1] INVASIVE PNEUMOCOCCAL DISEASE IN ALASKAN CHILDREN: THE ROLE OF WATER SUPPLY AND THE SEVEN VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV7)
    Wenger, J. D.
    Zulz, T.
    Bruden, D.
    Bruce, M. G.
    Bulkow, L.
    Parks, D.
    Rudolph, K.
    Hurlburt, D.
    Singleton, R.
    Ritter, T.
    Klejka, J.
    Hennessy, T.
    [J]. INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2010, 69 : 100 - 100
  • [2] Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele, Carolien
    Moore, Hannah
    Bayley, Kathy
    Harrison, Catherine
    Murphy, Denise
    Rooney, Kylie
    Keil, Anthony D.
    Lehmann, Deborah
    [J]. VACCINE, 2007, 25 (13) : 2379 - 2384
  • [3] The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine
    Fitzwater, Sean P.
    Chandran, Aruna
    Santosham, Mathuram
    Johnson, Hope L.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (05) : 501 - 508
  • [4] Effectiveness of seven-valent pneumococcal conjugate vaccine
    Beutels, Philippe
    Van Damme, Pierre
    [J]. LANCET, 2007, 369 (9560): : 460 - 460
  • [5] Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease
    Tamura, Kazuyo
    Matsubara, Kousaku
    Ishiwada, Naruhiko
    Nishi, Junichiro
    Ohnishi, Hidenori
    Suga, Shigeru
    Ihara, Toshiaki
    Chang, Bin
    Akeda, Yukihiro
    Oishi, Kazunori
    [J]. VACCINE, 2014, 32 (13) : 1444 - 1450
  • [6] Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
    Biesbroek, Giske
    Wang, Xinhui
    Keijser, Bart J. F.
    Eijkemans, Rene M. J.
    Trzcinski, Krzysztof
    Rots, Nynke Y.
    Veenhoven, Reinier H.
    Sanders, Elisabeth A. M.
    Bogaert, Debby
    [J]. EMERGING INFECTIOUS DISEASES, 2014, 20 (02) : 201 - 210
  • [7] Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine
    Suga, Shigeru
    Chang, Bin
    Asada, Kazutoyo
    Akeda, Hideki
    Nishi, Junichiro
    Okada, Kenji
    Wakiguchi, Hiroshi
    Maeda, Akihiko
    Oda, Megumi
    Ishiwada, Naruhiko
    Saitoh, Akihiko
    Oishi, Tomohiro
    Hosoya, Mitsuaki
    Togashi, Takehiro
    Oishi, Kazunori
    Ihara, Toshiaki
    [J]. VACCINE, 2015, 33 (45) : 6054 - 6060
  • [8] Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
    Whitney, Cynthia G.
    Pilishvili, Tamor
    Farley, Monica M.
    Schaffner, William
    Craig, Allen S.
    Lynfield, Ruth
    Nyquist, Ann-Christine
    Gershman, Kenneth A.
    Vazquez, Marietta
    Bennett, Nancy M.
    Reingold, Arthur
    Thomas, Ann
    Glode, Mary P.
    Zell, Elizabeth R.
    Jorgensen, James H.
    Beall, Bernard
    Schuchat, Anne
    [J]. LANCET, 2006, 368 (9546): : 1495 - 1502
  • [9] The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children
    Palmu, AAI
    Verho, J
    Jokinen, J
    Karma, P
    Kilpi, TM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (08) : 732 - 738
  • [10] A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain
    Asensi, F
    De Jose, M
    Lorente, M
    Moraga, F
    Ciuryla, V
    Arikian, S
    Casciano, R
    Vento, M
    [J]. VALUE IN HEALTH, 2004, 7 (01) : 36 - 51